Joel Block to Alternative Splicing
This is a "connection" page, showing publications Joel Block has written about Alternative Splicing.
Connection Strength
0.068
-
The clinical significance of tenascin-C splice variant expression in chondrosarcoma. Oncology. 2001; 61(4):306-14.
Score: 0.045
-
Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma. Gene. 2002 Feb 20; 285(1-2):269-78.
Score: 0.012
-
Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin. Cell Struct Funct. 2001 Jun; 26(3):179-87.
Score: 0.012